In 2 randomized clinical trials, investigators sought to determine if use of vitamin D supplements improved PFS and RFS for patients with digestive tract cancers.
Many clinical and ethical factors influence whether preemptive transplant would be beneficial for patients genetically predisposed to acute myeloid leukemia.
This fact sheet explains the processes involved in drug development and FDA drug approval.
[Blood and Lymphatic Cancer: Targets and Therapy] This study analyzes the clinical outcomes reported with IDH1mut inhibitors and other agents in adult patients with IDH1mut R/R AML.
CancerCare explains how cancer risks and care differ between transgender persons and the general population.
This fact sheet examines the relationship between the HCAs and PAHs produced by cooking meats and cancer risk.
The increased prevalence may be real, or it could be the result of the detection of more harmless tumors through increased screening efforts.
What can be done to avoid misinformation and establish trust between the patient and caregiver and the oncology nurse?
The approval of novel oral therapeutic agents may offer a more cost-effective treatment option for acute myeloid leukemia.
[Lung Cancer: Targets and Therapy] This research examines examine the clinical trial data that evaluated the combination of chemotherapy with immune checkpoint inhibitors for the front-line treatment of advanced NSCLC patients.
The term noncompliant assumes in part that the patient has accepted the premise of what they are instructed to comply with.
[Cancer Management and Research] The aim of this study was to establish a prognostic estimation of CHCs after resection (PECAR) score predicting recurrence on the basis of the clinicopathological data.
This data analysis examined the effect of alcohol consumption on the risk of lethal prostate cancer in men at risk of the disease, and those who developed nonmetastatic prostate cancer during follow-up.
[Cancer Management and Research] In this report, researchers review evidence to date on the effectiveness of immune checkpoint inhibitors in combination for the treatment of non-small cell lung cancer.
A presentation of a patient navigation model that functions as a multidisciplinary team effort.